These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 7810635)

  • 1. Mineralocorticoid antagonist inhibits stress-induced blood pressure response after repeated daily warming.
    Van den Berg DT; de Jong W; de Kloet ER
    Am J Physiol; 1994 Dec; 267(6 Pt 1):E921-6. PubMed ID: 7810635
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intracerebroventricular administration of a glucocorticoid receptor antagonist enhances the cardiovascular responses to brief restraint stress.
    Van Acker SA; Fluttert MF; Sibug RM; De Kloet ER
    Eur J Pharmacol; 2001 Oct; 430(1):87-91. PubMed ID: 11698067
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Central effects of mineralocorticoid antagonist RU-28318 on blood pressure of DOCA-salt hypertensive rats.
    Van den Berg DT; de Kloet ER; de Jong W
    Am J Physiol; 1994 Dec; 267(6 Pt 1):E927-33. PubMed ID: 7810636
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of brain corticosterone and aldosterone in central angiotensin II-induced hypertension.
    Huang BS; White RA; Ahmad M; Leenen FH
    Hypertension; 2013 Sep; 62(3):564-71. PubMed ID: 23856493
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differential central effects of mineralocorticoid and glucocorticoid agonists and antagonists on blood pressure.
    van den Berg DT; de Kloet ER; van Dijken HH; de Jong W
    Endocrinology; 1990 Jan; 126(1):118-24. PubMed ID: 2293978
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Influence of sodium intake on the cardiovascular and renal effects of brain mineralocorticoid receptor blockade in normotensive rats.
    Rahmouni K; Barthelmebs M; Grima M; Imbs JL; De Jong W
    J Hypertens; 2002 Sep; 20(9):1829-34. PubMed ID: 12195126
    [TBL] [Abstract][Full Text] [Related]  

  • 7. On the role of brain mineralocorticoid (type I) and glucocorticoid (type II) receptors in neuroendocrine regulation.
    Ratka A; Sutanto W; Bloemers M; de Kloet ER
    Neuroendocrinology; 1989 Aug; 50(2):117-23. PubMed ID: 2550833
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Glucocorticoid and mineralocorticoid receptors are involved in the facilitation of anxiety-like response induced by restraint.
    Calvo N; Volosin M
    Neuroendocrinology; 2001 Apr; 73(4):261-71. PubMed ID: 11340340
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Brain mineralocorticoid receptor control of blood pressure and kidney function in normotensive rats.
    Rahmouni K; Barthelmebs M; Grima M; Imbs JL; Wybren De Jong
    Hypertension; 1999 May; 33(5):1201-6. PubMed ID: 10334812
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cardiovascular and renal effects of central administration of a mineralocorticoid receptor antagonist in conscious female rats.
    Rahmouni K; Barthelmebs M; Grima M; Imbs JL; De Jong W
    Eur J Pharmacol; 1999 Dec; 385(2-3):199-202. PubMed ID: 10607876
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mineralocorticoid receptor antagonists attenuate exaggerated exercise pressor reflex responses in hypertensive rats.
    Downey RM; Mizuno M; Mitchell JH; Vongpatanasin W; Smith SA
    Am J Physiol Heart Circ Physiol; 2017 Oct; 313(4):H788-H794. PubMed ID: 28733447
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Angiotensin and mineralocorticoid receptor antagonism attenuates cardiac oxidative stress in angiotensin II-infused rats.
    Minas JN; Thorwald MA; Conte D; Vázquez-Medina JP; Nishiyama A; Ortiz RM
    Clin Exp Pharmacol Physiol; 2015 Nov; 42(11):1178-88. PubMed ID: 26234762
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evidence for mineralocorticoid receptor facilitation of glucocorticoid receptor-dependent regulation of hypothalamic-pituitary-adrenal axis activity.
    Spencer RL; Kim PJ; Kalman BA; Cole MA
    Endocrinology; 1998 Jun; 139(6):2718-26. PubMed ID: 9607777
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anxiolytic-like effects of selective mineralocorticoid and glucocorticoid antagonists on fear-enhanced behavior in the elevated plus-maze.
    Korte SM; de Boer SF; de Kloet ER; Bohus B
    Psychoneuroendocrinology; 1995; 20(4):385-94. PubMed ID: 8532822
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Brain mineralocorticoid receptor and blood pressure control in the conscious normotensive rat].
    Rahmouni K; Barthelmebs M; Imbs JL; De Jong W
    Arch Mal Coeur Vaiss; 1998 Aug; 91(8):1009-12. PubMed ID: 9749155
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Paradoxical mineralocorticoid receptor-mediated effect in fear memory encoding and expression of rats submitted to an olfactory fear conditioning task.
    Souza RR; Dal Bó S; de Kloet ER; Oitzl MS; Carobrez AP
    Neuropharmacology; 2014 Apr; 79():201-11. PubMed ID: 24296155
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Central mineralocorticoid receptors and the role of angiotensin II and glutamate in the paraventricular nucleus of rats with angiotensin II-induced hypertension.
    Gabor A; Leenen FH
    Hypertension; 2013 May; 61(5):1083-90. PubMed ID: 23509081
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Blockade of the mineralocorticoid receptor in healthy men: effects on experimentally induced panic symptoms, stress hormones, and cognition.
    Otte C; Moritz S; Yassouridis A; Koop M; Madrischewski AM; Wiedemann K; Kellner M
    Neuropsychopharmacology; 2007 Jan; 32(1):232-8. PubMed ID: 17035932
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Blockage of glucocorticoid, but not mineralocorticoid receptors prevents the persistent increase in circulating basal corticosterone concentrations following stress in the rat.
    Moldow RL; Beck KD; Weaver S; Servatius RJ
    Neurosci Lett; 2005 Feb; 374(1):25-8. PubMed ID: 15631890
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mineralocorticoid receptors mediate cardiac remodelling in morphine-dependent rats.
    Mesripour A; Iyer A; Brown L
    Basic Clin Pharmacol Toxicol; 2012 Aug; 111(2):75-80. PubMed ID: 22304485
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.